These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 1692981

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tumour markers in monitoring the treatment of advanced prostate cancer.
    Cooper EH, Armitage TG.
    Prog Clin Biol Res; 1990; 359():65-72; discussion 73-4. PubMed ID: 1704634
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical and pathological study of tumor marker in benign prostatic hypertrophy and incidental prostatic cancer].
    Sakai N, Ogawa T, Ishibashi Y, Fukuoka H, Sakanishi S.
    Hinyokika Kiyo; 1991 Jun; 37(6):589-94. PubMed ID: 1716409
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate].
    Morote Robles J, de Torres Mateos JA.
    Arch Esp Urol; 1989 Jun; 42 Suppl 2():124-30. PubMed ID: 2484148
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prostate-specific antigen: a valuable clinical tool.
    Oesterling JE.
    Oncology (Williston Park); 1991 Apr; 5(4):107-22; discussion 122, 125-6, 128. PubMed ID: 1714288
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic value of serum markers for prostate cancer.
    Stenman UH, Abrahamsson PA, Aus G, Lilja H, Bangma C, Hamdy FC, Boccon-Gibod L, Ekman P.
    Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prostate specific antigen: clinical use in the diagnosis and management of prostate cancer.
    Kabalin JN.
    Geriatrics; 1992 Sep; 47(9):26-32. PubMed ID: 1380941
    [Abstract] [Full Text] [Related]

  • 13. [The clinical use of the prostate-specific antigen in patients with prostatic cancer].
    Matveev BP, Sokolov AV, Bukharkin BV, Ledian KM, Tilk AE, Makarova GV.
    Urol Nefrol (Mosk); 1991 Sep; (4):8-12. PubMed ID: 1719686
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
    Bogdanowicz JF, Bentvelsen FM, Oosterom R, Schroeder FH.
    Scand J Urol Nephrol Suppl; 1991 Sep; 138():97-103. PubMed ID: 1723815
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic value of prostatic acid phosphatase and prostate-specific antigen in patients with prostatic cancer.
    Pagani F, Zambolin T, Bonora R, Panteghini M.
    J Nucl Med Allied Sci; 1990 Sep; 34(4 Suppl):85-7. PubMed ID: 1709211
    [Abstract] [Full Text] [Related]

  • 16. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T, Herawi M, Epstein JI, Illei PB.
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [Abstract] [Full Text] [Related]

  • 17. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
    Ersev A, Ersev D, Turkeri L, Ilker Y, Simsek F, Kullu S, Akdas A.
    Prog Clin Biol Res; 1990 Sep; 357():129-34. PubMed ID: 1699237
    [Abstract] [Full Text] [Related]

  • 18. [Tumor markers in prostate cancer].
    Kuriyama M.
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1915-22. PubMed ID: 7521999
    [Abstract] [Full Text] [Related]

  • 19. Prostate specific antigen in the diagnosis and staging of prostate cancer.
    Jung P, Wolff JM, Mattelaer P, Jakse G.
    Acta Urol Belg; 1996 Sep; 64(3):1-6. PubMed ID: 8946774
    [Abstract] [Full Text] [Related]

  • 20. [Role of prostate-specific antigen in prostatic carcinoma. Validity of an integrated methodologic approach and morpho-biological correlations].
    Tomasino RM, Lo Bianco A, Cacciatore M, Pavone C, Carreca I, Morello V, Salvato M, Florena AM, Pavone-Macaluso M.
    Pathologica; 1989 Sep; 81(1072):109-26. PubMed ID: 2475847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.